Physician profile
Daniel A Dileo
NPI 1609280247
$3,786.00
in general payments reported to CMS, 2019-2025
16 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,686 · 2020: $39.21 · 2021: $193 · 2022: $117 · 2023: $196 · 2024: $190 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,046 · Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,045.83 |
| Food and Beverage | $704.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $1,238.12 | 2025 | |
| Abbvie INC. | $634.84 | 2019-2020 | |
| Gilead Sciences, INC. | $611.69 | 2019-2025 | Epclusa |
| Janssen Pharmaceuticals, INC | $234.99 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.13 | 2019 | |
| Boston Scientific Corporation | $143.84 | 2019-2023 | |
| Dova Pharmaceuticals | $138.73 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Zeposia |
| Alexion Pharmaceuticals, INC. | $124.00 | 2019 | |
| Amarin Pharma, INC. | $105.00 | 2019 | |
| Olympus Corporation of The Americas | $71.41 | 2019 | |
| Redhill Biopharma INC. | $67.88 | 2021 | |
| Capsovision, INC. | $51.60 | 2023-2024 | Capsocam Plus |
| Janssen Biotech, INC. | $29.66 | 2024 | Stelara |
| Medtronic, INC. | $23.12 | 2024 | Manoscan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $17.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dileo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.